ArticleChina CDC weekly2025
HIV Prevention Cascade and PrEP/PEP Implementation Gaps Among High-Risk University Students - Sichuan Province, China, 2022-2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Chinese university students face elevated human immunodeficiency virus (HIV) risks, yet pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) uptake remain low despite proven efficacy. What is added by this report?: Among 645 high-risk students, 12.87% utilized PrEP and 13.02% utilized PEP. High HIV knowledge strongly predicted awareness [PrEP: adjusted odds ratio (a What are the implications for public health practice?: Educational interventions alone are insufficient to improve service uptake; comprehensive strategies that simultaneously address both knowledge deficits and systemic barriers are essential for expanding PrEP and PEP access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.